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ABSTRACT
Techniques for targeted genetic disruption in
Plasmodium, the causative agent of malaria, are
currently intractable for those genes that are essen-
tial for blood stage development. The ability to use
RNA interference (RNAi) to silence gene expression
would provide a powerful means to gain valuable
insight into the pathogenic blood stages but its
functionality in Plasmodium remains controversial.
Here we have used various RNA-based gene silenc-
ing approaches to test the utility of RNAi in malaria
parasites and have undertaken an extensive com-
parative genomics search using profile hidden
Markov models to clarify whether RNAi machinery
exists in malaria. These investigative approaches
revealed that Plasmodium lacks the enzymology
required for RNAi-based ablation of gene expres-
sion and indeed no experimental evidence for RNAi
was observed. In its absence, the most likely expla-
nations for previously reported RNAi-mediated
knockdown are either the general toxicity of intro-
duced RNA (with global down-regulation of gene
expression) or a specific antisense effect mechanis-
tically distinct from RNAi, which will need system-
atic analysis if it is to be of use as a molecular
genetic tool for malaria parasites.
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved
mechanism found across a range of eukaryotes, where it
plays a key role in post-transcriptional gene regulation
and in the protection of genomes from intrinsic and extrin-
sic threats (1). With its exquisite speciﬁcity for the target
gene as well as its potent and reversible action, RNAi
technology has now become a standard technique in the
molecular toolbox for reverse genetic experimentation
in many systems, providing a quick and easy means to
gain valuable insight into gene function, in particular
those that are essential to cell viability. The process of
RNAi is triggered by the recognition of double-stranded
RNA (dsRNA), which is then processed into 21–25
nucleotide sequences by Dicer, a cytoplasmic dsRNA-
speciﬁc RNaseIII endonuclease (2–5). The processed
short interfering RNAs (siRNAs) that are generated asso-
ciate with an RNA-induced silencing complex (RISC) and
unwind in a strand-speciﬁc manner (3). The resulting
siRNAs are then able to target homologous mRNA for
degradation in combination with the RNaseH enzyme
Argonaute (Slicer) (6). The ﬁrst stage of dsRNA proces-
sing can be bypassed by introducing sequence-speciﬁc
siRNAs directly into cells.
The blood stage malaria parasite is responsible for all
of the debilitating clinical symptoms of the malaria disease
and is therefore a central focus of research to ﬁnd new
therapeutic approaches (7). The malaria parasite is hap-
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asexual forms that proliferate in the blood. Current tech-
nologies for the genetic manipulation of Plasmodium are
limited to this stage of parasite development, through the
introduction of exogenous DNA containing drug-resistant
markers and subsequent drug selection. It is self-evident,
therefore, that a malaria gene encoding a product essential
to blood stage asexual growth would be resistant to
permanent genetic disruption. Although two methods
have recently been developed that allow inducible expres-
sion in the most virulent human malaria parasite,
Plasmodium falciparum (8,9), neither has successfully
been utilized to create full inducible gene knockouts,
most likely because of an inherent leakiness in both sys-
tems. Given the immense burden of malaria disease and
the need for new drug targets, in particular those essential
for development of the pathogenic blood stages, the ability
to utilize a gene silencing approach such as RNAi would
clearly be extremely beneﬁcial.
To date there have been several reports describing
the use of RNAi for gene silencing in the blood stages
of Plasmodium. These have involved introducing either
long dsRNAs by direct electroporation into erythrocytes
infected with P. falciparum (10–12) or the addition of
siRNAs into the culture medium (13–16). In addition,
siRNAs have been injected into mice infected with the
rodent malaria parasite P. berghei (17). While these studies
suggest that RNAi may be functional in malaria parasites,
targeting of speciﬁc genes in all of these cases resulted in
parasite death or signiﬁcant growth defects. Since these
processes most probably lead to a global down-regulation
of expression of many genes, it will be diﬃcult to demon-
strate the speciﬁc eﬀect of the siRNA on expression of the
target gene. For example, based on RNAi targeting of
falcipain-1, a protease involved in the degradation path-
way for hemoglobin, it has been concluded that this pro-
tein is essential for P. falciparum blood-stage growth (14).
However, this ﬁnding is at odds with the demonstration
that disruption of this gene by standard knockout tech-
nologies has no apparent eﬀect on blood stage develop-
ment (18). These observations question the speciﬁcity of
gene targeting by siRNA’s in Plasmodium. Indeed, unpub-
lished observations [cited by Blackman (19)] have sug-
gested that the introduction of long dsRNA or siRNAs
directed against P. falciparum SUB-1 or AMA-1 did not
lead to silencing of expression of the target genes. In addi-
tion, several studies have been unable to detect even dis-
tant homologues of either Dicer or Argonaute in the
P. falciparum or P. berghei genomes (19–24) and two
recent studies failed to isolate P. falciparum micro-RNAs
(miRNAs), a class of endogenous regulatory short RNAs
that also act through the RNAi pathway (25,26).
However, the failure to detect in Plasmodium homologues
of the genes involved in RNAi silencing found in other
organisms might be due to the unusually high AT-content
of Plasmodium genomes which has notoriously caused
diﬃculties in identifying genes where there is poor conser-
vation. Therefore, the question of the presence of a highly
divergent RNAi machinery in Plasmodium remains open.
In an attempt to clarify whether RNAi is functional
in Plasmodium, we have taken a variety of RNA-based
strategies to target genes in P. falciparum and P. berghei
that are non-essential to growth or development and
analysed their expression. Additionally, we have under-
taken an extensive comparative analysis of available
Apicomplexan and other protozoan genomes using sensi-
tive proﬁle hidden Markov models of domains (rather
than simply sequence homology or PSI/RPS-BLAST
based searches) in an attempt to determine whether
a primitive RNAi machinery exists in Apicomplexa.
Together our data argue that RNAi is absent in malaria
parasites and therefore it is unlikely that RNAi-based gene
silencing will prove to be a reliable approach to unravel
the function of malaria proteins.
MATERIALS AND METHODS
Generation of RNA interference constructs
Two dsRNA hairpin structures were created—one based
on KAHRP for testing RNAi in P. falciparum and the
other based on CTRP for testing RNAi in P. berghei.
For the KAHRP hairpin structure, 407bp of the
KAHRP gene (PFB0100c) was PCR-ampliﬁed from 3D7
genomic DNA using the oligonucleotides RNAiF and
RNAiR or RNAiF(H/X) and RNAiR (Figure 1A,
Supplementary Data S1 for oligonucleotide sequences).
A luciferase stuﬀer region of 437bp was ampliﬁed from
pDluc^D (27) using the oligonucleotides lucF and lucR.
The PCR products were cloned sequentially into pHH1
(28) to create plasmid pHH/KRNAi (Figure 1A). For
the CTRP hairpin structure, a 2.7kb promoter fragment
upstream of the translation initiation codon of CTRP
(PB000233.00.0) was ampliﬁed from genomic DNA of
the P. berghei line cl5cy11 (HP) with oligonucleotides
CpXbaI and CpClaI. For the CTRP inverted repeat,
680bp of the CTRP ORF was PCR ampliﬁed using
oligonucleotides 764 and 770 or 769 and 770. A 270bp
stuﬀer fragment separating the inverted CTRP fragments
was ampliﬁed from Anopheles gambiae genomic DNA
using the oligonucleotides 749 and 750. The P28 30UTR
was ampliﬁed using oligonucleotides 753 and 754. These
fragments were all cloned sequentially to yield the ﬁnal
plasmid construct pCTRPdsRNA (Figure 2A).
To assess whether antisense mRNA can silence gene
expression in P. falciparum, the constructs pHH/lucS
and pHH/lucAS were constructed (Figure 3A). The con-
structs pHH/lucS and pCC4/lucS are based on pHH1 or
pCC4, respectively and harbour the luciferase gene in the
sense orientation relative to the hsp86 50 untranslated
region, whereas pHH/lucAS harbours the luciferase gene
in the antisense orientation. The vector pHH/CAT har-
bours the chloramphenicol acetyl transferase gene in place
of the luciferase gene (29).
P. falciparum culturing and transfection
Parasite cultures of P. falciparum 3D7 and D10 were
maintained and synchronized as per standard procedures.
Stable transfections with pHH/KRNAi and transient tras-
fections with various combinations of sense and antisense
constructs are described in the Supplementary Data.
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Asexual stage P. berghei parasites (HP line) were trans-
fected with pCTRPdsRNA according to Janse et al.
(30). Parasites resistant to pyrimethamine selection were
cloned by limiting dilution. Three parasite clones
(299cl1, 2 and 3) were positive for integration into the
C or D SSU (Supplementary Data); clone 2 was chosen
for further experiments.
siRNA design and introduction into culture
Four independent siRNAs (to avert possible non-
functionality of any single RNAi) were designed for
three genes that have previously been knocked out in
3D7: KAHRP (31), PfRh2a (32) and EBA175 (33) (see
Supplementary Data S2 for sequences). The siRNAs
were used at 50–200mg/ml ﬁnal concentration as described
previously (15,16). 0.5ml of culture at ring-stages follow-
ing sorbitol treatment ( 8–12h) was incubated with each
siRNAs in a 24-well culture plate in serum free medium
for 30min with intermittent mixing. Subsequently,
Albumax
TM (Gibco BRL) was added at a ﬁnal concentra-
tion of 10% and parasites were maintained for 24h until
late trophozoite or schizogony. For immunoblot analysis
parasites were harvested at late schizogony ( 40h post
Figure 1. KAHRP dsRNA is transcribed in P. falciparum but does not silence endogenous KAHRP. (A) Schematic of the two exon structure of the
endogenous KAHRP locus and the construct pHH/KRNAi, created to generate dsRNA for silencing endogenous KAHRP. Large arrows above
pHH/KRNAi indicate direction of transcription and position of oligonucleotides used for PCR or RT–PCR are indicated by small arrowheads. The
human DHFR (hDHFR) selectable marker cassette is under the transcriptional control of the CAM 50 and HRP2 30 untranslated regions. Promoter
regions are symbolized by right-angled arrows and the 30 untranslated regions necessary for gene expression by a circle. (B) Transgenic 3D7/KRNAi
parasites transcribe dsRNA. Total RNA was isolated from asynchronized parental (3D7) or transgenic (3D7/KRNAi) parasites and cDNA was then
generated using oligo d(T) or a luciferase speciﬁc primer (lucR). RT–PCRs were performed with the oligonucleotides either in the presence (+) or
absence (–) of reverse transcriptase. As controls, genomic DNA (gDNA) isolated from 3D7 or pHH/KRNAi DNA was also used. (C) Northern blot
analysis of RNA isolated from 3D7 parental or 3D7/KRNAi transgenic parasites across the asexual life cycle (Exp1) or during the stage of parasite
development when KAHRP expression is at its peak (Exp2 and Exp3) using probes directed against luciferase (LUC), PF14_0344 or KAHRP
conﬁrms the KAHRP hairpin structure is transcribed yet is not capable of destabilizing KAHRP mRNA. The percentage of relative KAHRP
expression was calculated by determining the level of KAHRP transcripts relative to that of PF14_0344 for both 3D7/KRNAi and 3D7, with the
latter being normalized to 100%. ER, early ring-stages; R, rings; LR, late rings; ET, early trophozoites; LT, late trophozoites.
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are maximally expressed) or trophozoites ( 20–24h when
KAHRP is maximally expressed), lysed with saponin and
resuspended in reducing buﬀer. Immunoblots were probed
with speciﬁc antibodies against each target protein
[KAHRP (31), PfRh2a (32) and EBA175 (33), MTRAP
or GAP50 (34)]. A portion of each parasite culture was
retained and allowed to reinvade new erythrocytes.
Percentage invasion relative to untreated controls was
measured as previously described (35).
RESULTS
Stable expression of a dsRNA hairpin does not effectively
silence expression of P. falciparum and P. berghei genes
To determine whether transcription of a gene could be
silenced using RNAi in P. falciparum, a double-stranded
hairpin construct was made which was designed to specif-
ically target the gene KAHRP (PFB0100c), in a manner
similar to that described for Trypanosoma brucei, a proto-
zan pathogen in which RNAi has been validated (36).
KAHRP is known to be non-essential to the blood
stages as knockout parasites are viable, although they
do have a distinct phenotype (31). The construct pHH/
KRNAi contains two opposing KAHRP fragments sepa-
rated by a non-P. falciparum ‘stuﬀer’ region derived from
a portion of the ﬁreﬂy luciferase gene with expression
driven by the P. falciparum HSP86 promoter region.
This construct was transfected into the 3D7 parasite line
pre-selected for the presence of knobs and hence expres-
sion of KAHRP, with stable transfectants termed
3D7/KRNAi. Transcription of the dsRNA transgene in
P. falciparum was investigated using both RT–PCR and
Northern blot analysis (see Supplementary Data for meth-
ods). Endogenous KAHRP was successfully ampliﬁed
Figure 2. CTRP dsRNA does not silence endogenous CTRP during P. berghei ookinete development. (A) Schematic representation of the endo-
genous CTRP locus and the construct pCTRPdsRNA used to generate dsRNA for silencing endogenous CTRP. Large arrows above pCTRPdsRNA
indicate direction of transcription and position of oligonucleotides used for PCR or RT–PCR are indicated by small arrowheads. The T. gondii
DHFR (TgDHFR/TS) selectable marker cassette is under the transcriptional control of the P. berghei DHFR 50 and DHFR 30 untranslated regions.
Promoter regions are symbolized by right-angled arrows and the 30 untranslated regions necessary for gene expression by a circle. (B) Transgenic
P. berghei 299cl2 transcribe dsRNA. Total RNA was isolated from an in vitro ookinete culture of HP parental and transgenic 299cl2 lines 16-h post-
induction and cDNA was then generated using oligo d(T). RT–PCRs were performed with the oligonucleotides shown, either in the presence (+) or
absence (–) of reverse transcriptase. As a control pCTRP/dsRNA DNA was also used. (C) Comparison of steady state levels of CTRP and WARP
RNA during ookinete development (4–20-h post-induction) by Northern blot analysis. Two independent 299cl2 RNA samples are shown. (D) Ratios
of CTRP versus WARP RNA levels in parental HP (two samples) and 299cl2 (three samples). None of the diﬀerences are signiﬁcant (unpaired t-test).
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3D7/KRNAi whilst no product could be detected with
cDNA made from a KAHRP knockout line (37)
conﬁrming the speciﬁcity of the reaction (Figure 1B and
data not shown). dsRNA-speciﬁc cDNA ampliﬁcation
was, however, only observed in parasites transfected
with pHH/KRNAi, indicating that the hairpin structure
is indeed transcribed in 3D7/KRNAi (Figure 1B). This
was also conﬁrmed by Northern blot analysis of RNA
isolated from the two lines and probed with the LUC
stuﬀer region (Figure 1C, top panel). As expected, bands
corresponding to LUC transcript were detected in the
transfected parasite line 3D7/KRNAi, but not in the
wild-type 3D7line.
Having established stable expression of KAHRP
dsRNA, we next sought to determine whether transcrip-
tion of the transgene resulted in modulation of the
amount of KAHRP transcripts. Northern blots of RNA
isolated from 3D7 and 3D7/KRNAi that were hybridized
with a probe which recognizes only endogenous KAHRP
and not the dsRNA transcript revealed that the pres-
ence of the hairpin structure did not aﬀect the levels of
KAHRP expression (Figure 1C). To safeguard against
asynchrony between the two lines, parasites were har-
vested at diﬀerent time points during their life cycle and
the transcription levels of KAHRP relative to PF14_0344
(an unrelated gene chosen as a control) in the 3D7/
KRNAi line were normalized to levels obtained for
3D7. Accounting for possible asynchrony, and despite
the presence of highly abundant dsRNA transcripts pres-
ent in the 3D7/KRNAi line (Figure 1C, Exp1), no gene
silencing eﬀect was observed. Indeed, by the latter time
points there was actually more KAHRP expression rela-
tive to PF14_0344 in the 3D7/KRNAi line than in the
3D7 wild-type line with overall cumulative transcrip-
tional expression for KAHRP being 86.1% in transfectant
versus wild-type. Two repeat experiments (Exp2 and
Exp3), this time at the late ring and early trophozoite
stages when KAHRP expression is at its peak showed
similar results. Together this data strongly suggests that
the KAHRP dsRNA was unable to eﬃciently destabilize
the amount of steady state endogenous KAHRP mRNA
at least to any levels that could be used to analyse gene
function.
Similar results were obtained in our attempts with the
rodent malaria parasite P. berghei. A plasmid construct
containing a 680bp inverted CTRP repeat separated by
a stuﬀer fragment from A. gambiae was stably introduced
into the C/D-SSU unit on chromosomes 5 and 6 of
P. berghei (Figure 2A). The CTRP gene (PB000233.00.0)
encodes a surface receptor essential to insect stage parasite
development (motility), but is not expressed in blood stage
parasites and should therefore be amenable to knockdown
or knockout (38). Here, transcription of the dsRNA was
placed under the control of the CTRP promoter, ensuring
that its expression was transcribed at the same time as
the target mRNA. Using three diﬀerent oligonucleotide
combinations it was conﬁrmed that the dsRNA was tran-
scribed in transgenic 299cl2 insect stage ookinetes
(Figure 2B, see Supplementary Data for methods).
The ability of this dsRNA to speciﬁcally destabilize
endogenous CTRP mRNA in ookinetes was then investi-
gated by Northern analysis of parental P. berghei HP and
transgenic 299cl2 parasites at 4, 8, 12, 16 and 20h post-
induction (hpi) of sexual development using a CTRP
probe that recognizes only endogenous mRNA and not
the dsRNA (Figure 2C, see Supplementary Data for meth-
ods). As expected, transcription of CTRP in all cultures
increased steadily and peaked at 16hpi during ookinete
development. When the ratio of expression was calculated
relative to WARP (PB000020.03.0), an ookinete spe-
ciﬁc gene that has a similar temporal expression patterns
to CTRP, it was revealed that any down-regulation
of CTRP was not signiﬁcant (Figure 2C and D).
Furthermore, at 12 and 13min post-induction exﬂagela-
tion centres were counted and the ookinete conversion
rates calculated (data not shown). No diﬀerences in devel-
opment were observed between the parental and trans-
genic 229cl2 parasite lines indicating that there were no
signiﬁcant oﬀ-target eﬀects as a result of the transgene
expression. This adds further support to our data from
P. falciparum that dsRNA is not eﬀective at silencing
gene expression in malaria parasites.
Generation of antisense mRNA does not lead to gene
silencing in P. falciparum
In the absence of dsRNA-mediated silencing we next
sought to determine whether silencing could be achieved
using antisense mRNA. P. falciparum parasites were tran-
siently co-transfected with a range of constructs that
were designed to generate sense and/or antisense ﬁreﬂy
luciferase (F-luc) mRNA (Figure 3A). These parasites
were co-transfected with a construct containing the
Renilla luciferase (R-luc) gene in order to normalize
for the variation in transfection eﬃciency across diﬀer-
ent transient transfection experiments by measuring
R-luc activity. As can be observed from Figure 3B,
F-luc activity could be detected in parasites transfected
with either F-luc mRNA sense constructs, pHH/lucS or
pCC4/lucS alone, and in parasites co-transfected with
both pHH/lucS and pHH/CAT. Furthermore, as
expected, no F-luc activity could be detected in parasites
transfected with either the antisense construct pHH/lucAS
or with pHH/CAT alone. However, the co-transfection of
antisense and sense F-luc mRNA constructs together
(pHH/lucAS with either pHH/lucS or pCC4/lucS) did
not lead to reduction in F-luc activity in two independent
transfections (Figure 2B) or in a repeat experiment (data
not shown). The inability of antisense mRNA from F-luc
to silence luciferase expression from sense mRNA strongly
suggests that antisense mRNA is not a general mechanism
of gene silencing in malaria parasites.
Introduction of exogenous siRNAs does not lead to gene
silencing in P. falciparum
In the absence of evidence that full length RNA constructs
can mediate eﬀective gene silencing in P. falciparum,w e
sought to determine whether we could bypass the need for
RNA processing and use exogenously introduced siRNAs
to disrupt gene expression. 3D7 parasites were incubated
with independent siRNAs (to detect possible experimental
3792 Nucleic Acids Research, 2009, Vol. 37,No. 11variation among siRNAs) at at least two diﬀerent concen-
trations (50, 100 or 200mg/ml). The target genes included
the non-essential genes KAHRP, PfRh2b (MAL13P1.176)
and EBA-175 (PF07_0128) as well as two putatively essen-
tial genes, MTRAP (PF10_0281) and GAP50 (PFI0880c)
(34). As a negative control a scrambled siRNA with no
homology to the P. falciparum 3D7 genome was used.
These experiments were performed following protocols
used in those studies that have reported successful
siRNA-mediated gene silencing in Plasmodium (13–16).
After co-culture of blood stage parasites with the
siRNA, parasites were harvested and the targeted protein
levels investigated by immunoblot. Although the protein
levels of the targeted genes did vary relative to the levels of
the PfAldolase (PF14_0425) protein [used as a loading
control (34)], no consistent or siRNA-concentration
dependent reduction in protein expression was observed
for any protein targeted by the siRNA (Figure 4).
Furthermore, no reduction in growth rate of the blood
stages was seen following the siRNA treatment, with re-
invasion levels remaining consistent across all treatments
(data not shown). These results strongly suggest that
delivery of speciﬁc siRNAs to blood stages through the
culture medium did not lead to speciﬁc gene silencing in
P. falciparum.
Comparative genomics suggests malaria parasites lack the
core RNAi machinery components Argonaute and Dicer
Previous studies have noted that the RNAi machinery is
absent in P. falciparum (19–24), an observation that ﬁts
with our inability to ﬁnd experimental evidence for RNAi
in both P. falciparum or P. berghei. To address the possi-
bility that a primitive RNAi machinery might be present,
that is highly divergent from—but structurally related
to—that of other eukaryotes, we performed a sensitive
comparative search of protein sequences from 18 eukary-
otic species, including two Plasmodium species and three
other apicomplexan and four kinetoplastid protozoan
parasites, for key domains involved in RNAi using proﬁle
hidden Markov models (HMMs) (see Supplementary
Data for methods). Also included in the cohort of ana-
lysed genomes were those of species that are known to
either perform RNAi (positive controls) or not (negative
controls). Domain proﬁle HMMs used included RNase3,
double-stranded RNA binding motifs (dsrm) and
double-stranded RNA-binding domains (dsRBD) for
Dicer orthologues and PAZ and Piwi domains for
Argonaute orthologues (2). This method, which has been
successfully used to detect Plasmodium proteins that have
low sequence similarity to non-malaria proteins (39),
greatly improves the chances of ﬁnding divergent
Figure 3. Expression of antisense mRNA fails to knock-down transient luciferase activity. (A) Schematic of two constructs, pHH/lucS and pHH/
lucAS, designed to generate sense or antisense luciferase mRNA in P. falciparum, respectively. The large arrow indicates the direction of transcrip-
tion. (B) Luciferase activity observed in parasite extracts transiently transfected with various plasmid combinations. The level of ﬁreﬂy luciferase was
normalized to the level of R. reniformis luciferase to control for variation in transfection eﬃciency across experiments. The ﬁreﬂy luciferase activity
observed in parasites transfected with pHH/lucS and pCC4/lucS were set at 100%, with all other luciferase activities observed in other transfected
parasites containing pHH/lucS or pCC4/lucS expressed relative to these, respectively. No antisense/sense mediated knockdown of luciferase activity
can be seen, irrespective of vector source for luciferase expression.
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teins. To further increase the chances of ﬁnding such
homologues in P. falciparum, a high E-value threshold
was used in addition to post hoc analyses of the over-pre-
dicted sequences looking for domain co-occurrence and by
performing reciprocal domain searches and phylogenetic
analysis. Unlike simple homology searches, including the
use of PSI-BLAST, this comparative approach provides
stronger support for protein absence where domains and
domain co-occurrences are not present across entire phy-
logenetic clades. Furthermore, the inclusion of positive
and negative controls allows us to monitor sensitivity
and speciﬁcity. The results of all domain predictions
across the 18 species are shown in Supplementary Data
S3. The results of PAZ and Piwi domain proﬁle searches,
using both a high E-value threshold (10) and moderately
conservative threshold (0.001), are summarized in Table 1,
which shows the number of proteins found that contain
predicted Piwi or PAZ domains for each species as well as
co-occurring predicted Piwi and PAZ domains (E-value
 10). While sensitive HMM searches with a high
E-value threshold predict six putative Piwi and 46 putative
PAZ domains in P. falciparum, more conservative
searches found none (Table 1). Furthermore, looking for
proteins containing both a PAZ and a Piwi domain using
a high E-value cut-oﬀ (10), we again found none in
P. falciparum. This was recapitulated with searches using
the sister species P. yoelii. The absence of proteins with
a PAZ or Piwi domain as deﬁned by the criteria used in
this study supports the idea that Plasmodium does not
contain an Argonaute homologue, not even a highly diver-
gent one. As a control, the same search approach that we
had applied to Plasmodium conﬁrmed the absence of a
true Argonaute in the yeast Saccharomyces cerevisiae,
whilst demonstrating its presence in Schizosaccharomyces
pombe; results that match the known utility of RNAi in
these organisms (24). Similarly, T. brucei is known to be
RNAi positive (20), whilst sister species T. cruzi and the
related trypanosomatid L. major are unable to perform
RNAi and our search strategy supported these observa-
tions, detecting Argonaute homologies only in T. brucei
(Table 1) (40,41). Of note, we identiﬁed in the apicom-
plexan Theileria annulata a hypothetical protein,
TA13085, which contains weak matches to both PAZ
and Piwi domains suggesting it may have an active
Argonaute. However, the position of TA13085 amongst
low scoring apicomplexan domain predictions on the PAZ
phylogenetic tree (Supplementary Data S4) may indicate
that it is a false positive and its putative function as an
Argonaute requires experimental veriﬁcation. Consistent
with the absence of putative Argonaute homologs
in Plasmodium, no Dicer/Drosha-like proteins could
be detected in Plasmodium when searching using domain
proﬁles consisting of two RNase3 domains or an RNase3
domain and a double stranded RNA binding domain
Figure 4. Exogenous introduction of siRNAs fails to knock-down
endogenous protein levels. Immunoblots for ﬁve genes targeted by
siRNAs speciﬁc for four (MTRAP 3 only and scrambled negative con-
trol) distinct regions of genes known to be tractable (KAHRP, EBA175
and PfRh2a) or intractable (MTRAP and GAP50) to conventional
knockout. Despite incubation at concentrations up to 100–200mg/ml
no consistent reduction in protein level can be seen for any gene.
Table 1. Number of putative proteins containing predicted Piwi or
PAZ domains or both domains across diverse eukaryotic species
Species E-values
a
Piwi PAZ PAZ+Piwi
b
10 10
–3 10 10
–3 10
Homo sapiens 16 11 15 12 10
Drosophila melanogaster 12 11 16 12 11
Caenorhabditis elegans 39 35 39 33 31
S. cerevisiae 10 0 17 0 0
S. pombe 51 1 21 1
Trichomonas vaginalis 32 50 2
Giardia intestinalis 1 0 19 01
Dictyostelium discoideum 17 5 52 5 6
Enthamoeba histolyca 12 3 25 2 3
T. brucei 32 60 1
T. cruzi 21 40 0
Leishmania major 41 50 0
Leishmania braziliensis 61 21 1
Toxoplasma gondii 41 4 1
c 1
c
Cryptosporidium parvum 24 0 38 0 0
T. annulata 18 0 23 0 1
P. falciparum 60 4 60 0
P. yoelli 12 0 38 0 0
aDomains were predicted using proﬁle HMMs with sensitive (10) and
conservative (10
–3) E-value thresholds.
bIndicates the number of proteins containing both a PAZ and a Piwi
domain.
cThe PAZ domain of the TgAGO homolog is upstream of the
annotated ATG start codon.
3794 Nucleic Acids Research, 2009, Vol. 37,No. 11(either dsrm or dsRNA_bind), either individually (using a
low E-value threshold) or in combination (using a high
cut-oﬀ) (Supplementary Data S5). Searches in other spe-
cies were consistent with their known ability to undertake
RNAi.
As a ﬁnal stringent test to rule out the presence of low
homology domains, a phylogenetic analysis of PAZ and
Piwi domains was undertaken (Supplementary Data S4
and S6). Phylogenetic trees of all predictions (E-value
<2) show that proteins containing high scoring Piwi and
PAZ domains cluster into groups. Low-scoring domains
are however interspersed throughout the tree and have
consistently longer branch lengths. This suggests that
low scoring hits are either highly divergent homologues
or unrelated proteins. The latter conclusion is supported
by the fact that the low scoring Piwi domains in
these proteins typically do not co-occur with a PAZ
domain, arguing that these proteins are not true
Argonaute-like proteins. Indeed, as shown in Table 2,
the best scoring domain that overlaps each low-scoring
Piwi domain in P. falciparum (analogous to the
Reciprocal Best Hits), has a highly signiﬁcant match to
an alternative domain which is a much better predictor
of the protein’s function. Taken together, the failure to
detect proteins containing Argonaute- and Dicer-like
domains using this sensitive comparative genomics
approach strongly suggests that Argonaute-like and
other RNAi-related proteins are absent in Plasmodium,
supporting earlier studies.
DISCUSSION
Although several studies have reported the use of RNA
interference mechanisms for silencing gene expression in
malaria parasites, there is still little consensus about
whether the genus Plasmodium has an active RNAi path-
way. Importantly, the concept has not been supported
by a clear demonstration that the Plasmodium genome
contains any of the conserved RNAi machinery (e.g.
Argonaute, Dicer). Here we combined a novel bioinfor-
matics search of the Plasmodium genome with a variety of
biological investigations to establish if RNAi is a valid
investigational approach for protein function in
Plasmodium with a sound theoretical basis. In previous
studies that reported successful targeting of genes with
RNAi, the eﬀect of gene silencing was determined by mea-
suring only the general eﬀects on growth and/or metabo-
lism of the treated parasites. In our studies we attempted
to measure directly the eﬀect of RNAi on expression of
target genes with a clear predicted outcome if successful;
non-essential genes (outcome: does-dependent reductions
in transcript and protein levels and impaired functional-
ity), essential genes (outcome: dose-dependent parasite
death) and transgene reporters (outcome: dose-dependent
reduction in luminescence). Stable and abundant expres-
sion of dsRNA hairpins targeting transcripts in blood
stages of P. falciparum and in ookinetes of P. berghei
produced no signiﬁcant eﬀect on steady state levels of
their target mRNA species, precluding this approach for
the analysis of the function of these proteins. In order to
compensate for the absence of an obvious functional
orthologue of Dicer (see below) exogenously produced
siRNAs were introduced into the P. falciparum blood
stages using a similar approach to previous reports on
siRNA silencing of Plasmodium genes (13–16). Again, by
measuring the eﬀect on expression of ﬁve diﬀerent pro-
teins, some of which are associated with merozoite inva-
sion of erythrocytes, we did not ﬁnd consistent and
signiﬁcant reduction in protein expression for any of the
transcripts targeted and no reduction in merozoite inva-
sion where relevant. While we have no proof of the eﬃ-
ciency of uptake of siRNAs by P. falciparum, the
methodologies used to treat the parasites with siRNA
were based on protocols that have previously been
reported to give rise to successful siRNA-mediated gene
silencing in this and other species. It is possible that other
means of transfection such as electroporation of parasites
may be required to eﬃciently introduce siRNAs into the
cytoplasm of P. falciparum. However, in P. berghei we
used the highly eﬃcient Amaxa method of electroporation
(30) to introduce siRNAs that target reporter gene tran-
scripts [green ﬂuorescent protein (GFP) and luciferase]
that are expressed from integrated transgenes. Using a
variety of electroporation conditions, we were unable to
detect signiﬁcant reduction in the expression of GFP and
luciferase in transfected blood stages in multiple indepen-
dent experiments (data not shown). Although we again
have no proof of the eﬃciency of siRNA delivery into
P. berghei by these electroporation conditions, these
studies provide no indications that gene silencing by
Table 2. Reciprocal proﬁle HMM search of sequences containing best scoring Piwi domains found in P. falciparum
Accession Piwi domain Best overlapping domain
Location Score E-value
a Domain name Location Score E-value
b
PF11_0352 12–236  140.9 1.4 Thioredoxin 165–275 81.6 2.6 10
 21
PFL1370w 29–258  140.9 1.4 Pkinase 15–298 246.8 4.7 10
 71
PF11_0059 14–252  146.9 3.5 MFS_1 17–374 5.5 0.012
PFI1125c 10–255  149.1 4.9 adh_short 61–228 142.8 9.9 10
 40
PF10_0245 456–672  151.4 6.9 SIS 507–636 119.1 5.1 10
 15
PFL1545c 301–555  153.7 9.7 Cpn60_TCP1 89–615 559.5 3.4 10
 165
aE-values for Piwi were obtained using hmmsearch.
bE-values of the best overlapping domains were obtained using hmmpfam.
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protein function in Plasmodium. Lastly, antisense is
an approach that has been proven to be successful in
reducing mRNA levels in several other protozoan species
(42–47), however, transient transfection of P. falciparum
blood stages with plasmids that generated antisense tran-
scripts targeting a luciferase reporter gene did not reduce
the expression of luciferase.
Taken together, our studies do not support the observa-
tions of previous studies in which RNAi has been used to
silence genes. In one study, smaller molecular weight RNA
species were detected after introducing exogenous dsRNA
in the blood stages of P. falciparum and the presence of
these small RNAs interpreted as evidence of digestion
of the mature full length mRNA target by Dicer (14).
Our inability to achieve gene silencing with stably pro-
duced dsRNA at diﬀerent life cycle stages of the parasite
and the absence of proteins with Dicer domains in
Plasmodium (see below) might suggest that the small
RNAs simply reﬂect degradation of the introduced
dsRNA. In previous studies of siRNA-gene silencing
(13–16), a general defect in growth and/or metabolism of
the parasites has been reported. These defects might also
be explained not as the result of speciﬁc gene targeting but
as a result of non-speciﬁc inhibitory eﬀects. For example,
the very high concentrations of siRNAs used in these
studies (over 100mg/ml) may cause non-speciﬁc growth
inhibition of P. falciparum and consequently a global
down-regulation of gene expression. One suggestion is
that observed RNA-mediated silencing eﬀects in these
studies could have been due to an antisense phenomenon
(48), whereby the antisense transcripts annealed to the
mRNA, preventing processes such as translation by
ribosomes. Indeed, antisense transcripts have been exten-
sively detected in the transcriptomes of P. falciparum
although their functional signiﬁcance remains obscure
(49–51). In our hands, however, we found no evidence
for antisense mediated silencing of expression when we
targeted the expression of the reporter protein luciferase
with antisense mRNA.
The lack of experimental evidence in our studies for the
presence of an active RNAi machinery in Plasmodium is
given credence by the current and previous failures to
bioinformatically identify Dicer and Argonaute ortholo-
gues in P. falciparum and P. yoelli. PAZ and Piwi domains
have been found in all functional Argonaute proteins iden-
tiﬁed to date (2), and while low scoring hits to these
domains were observed in several P. falciparum proteins,
the two domains were never found to co-occur within a
single protein. Furthermore, all the putative Piwi domain
sequences that were identiﬁed had a more signiﬁcant
match to an alternative domain in a reciprocal search.
Importantly, our bioinformatics analysis approach when
applied to other organisms that employ RNAi were in
keeping with those of previous studies (20,24). In general
the lack of Dicer and Argonaute homologies holds true for
all apicomplexan genomes examined. Besides the Theileria
protein that was noted, there is one further anomaly: the
T. gondii genome harbours a protein with a strong match
to Argonaute, although the PAZ domain in T. gondii
lies upstream of the putative start codon (52). This is
interesting from an evolutionary perspective as it may
present evidence for the loss of the RNAi machinery in
protozoans.
In other organisms RNAi plays a key role in biologi-
cal processes such as the control of endogenous gene
expression, the silencing of transposable elements and
repetitive genes or as a defence against viral attack (53).
The Plasmodium genome does not apparently possess ret-
rotransposons or viral pathogens, and thus there may be
no selective advantage to the malaria parasite in either
retaining (or gaining) an RNAi machinery (54).
Furthermore, native miRNAs, which are produced by
the cleavage of endogenous dsRNAs by Dicer to regulate
gene expression by inhibiting protein translation have not
been identiﬁed in P. falciparum infected red blood cells nor
in puriﬁed parasites (25,26).
In conclusion, our studies did not reveal any functional
or bioinformatics evidence for RNAi activity in
Plasmodium, indicating the absence of the RNAi machin-
ery and the inadvisability of the application of RNAi to
investigate gene function in Plasmodium. Although our
ﬁndings also indicate that gene regulation via antisense
inhibiting protein translation is non-functional in P. falci-
parum, the abundant native antisense transcripts found in
this organism leave open the question that antisense
regulation of gene activity may be gene-speciﬁc (55) and
thus further exploration of this technology in malaria
parasites may be warranted.
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ACKNOWLEDGEMENTS
We thank the Australian Red Cross Blood Bank for
the provision of human blood and serum and Fiona
Angrisano for technical assistance.
FUNDING
National Health and Medical Research Council
(NHMRC) of Australia; BIOMALPAR Network of
Excellence Grant and The Functional Genomics Initiative
of the Wellcome Trust; Career Development Award from
the NHMRC (to J.B.). A.F.C. is an International
Research Scholar of the Howard Hughes Medical Insti-
tute. Funding for open access charge: National Health and
Medical Research Council Project Grant 516740.
Conﬂict of interest statement. None declared.
REFERENCES
1. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism
and function. Cell, 116, 281–297.
2. Hammond,S.M. (2005) Dicing and splicing. The core machinery of
the RNA interference pathway. Febs Lett., 579, 5822–5829.
3. Nykanen,A., Haley,B. and Zamore,P.D. (2001) ATP requirements
and small interfering RNA structure in the RNA interference
pathway. Cell, 107, 309–321.
3796 Nucleic Acids Research, 2009, Vol. 37,No. 114. Bernstein,E., Caudy,A.A., Hammond,S.M. and Hannon,G.J. (2001)
Role for a bidentate ribonuclease in the initiation step of RNA
interference. Nature, 409, 363–366.
5. Ketting,R.F. (2001) Dicer functions in RNA interference and in
synthesis of small RNA involved in developmental timing in
C. elegans. Gene Dev., 15, 2654–2659.
6. Williams,R.W. and Rubin,G.M. (2002) ARGONAUTE1 is required
for eﬃcient RNA interference in Drosophila embryos. Proc. Natl
Acad. Sci. USA, 99, 6889–6894.
7. Miller,L.H., Baruch,D.I., Marsh,K. and Doumbo,O.K. (2002) The
pathogenic basis of malaria. Nature, 415, 673–679.
8. Meissner,M., Krejany,E., Gilson,P., de Koning-Ward,T., Soldati,D.
and Crabb,B. (2005) Tetracycline analogue-regulated transgene
expression in Plasmodium falciparum blood-stages using
Toxoplasma gondii transactivators. Proc. Natl Acad. Sci. USA, 102,
2980–2985.
9. Armstrong,C. and Goldberg,D. (2007) An FKBP destabilization
domain modulates protein levels in Plasmodium falciparum.
Nat. Methods, 4, 1007–1009.
10. McRobert,L. and McConkey,G.A. (2002) RNA interference
(RNAi) inhibits growth of Plasmodium falciparum. Mol. Biochem.
Parasitol., 119, 273–278.
11. Gissot,M., Briquet,S., Refour,P., Boschet,C. and Vaquero,C. (2005)
PfMyb1, a Plasmodium falciparum transcription factor, is required
for intra-erythrocytic growth and controls key genes for cell cycle
regulation. J. Mol. Biol., 34, 29–42.
12. Tuteja,R., Pradhan,A. and Sharma,S. (2008) Plasmodium
falciparum signal peptidase is regulated by phosphorylation and
required for intra-erythrocytic growth. Mol. Biochem. Parasitol.,
157, 137–147.
13. Kumar,R., Adams,B., Oldenburg,A., Musiyenko,A. and Barik,S.
(2002) Characterisation and expression of a PP1 serine/threonine
protein phosphatase (PfPP1) from the malaria parasite, Plasmodium
falciparum: demonstration of its essential role using RNA
interference. Malar. J., 145, 1245–1254.
14. Malhotra,P., Dasaradhi,P.V.N. and Chauhan,V. (2002)
Double-stranded RNA mediated gene silencing of the cysteine
proteases falcipain 1 and 2 in Plasmodium falciparum. Mol. Micro.,
45, 1245–1254.
15. Dasaradhi,P.V., Mohmmed,A., Kumar,A., Hossain,M.J.,
Bhatnagar,R.K., Chauhan,V.S. and Malhotra,P. (2005) A role of
falcipain-2, principal cysteine proteases of Plasmodium falciparum in
merozoite egression. Biochem. Biophys. Res. Commun., 336,
1062–1068.
16. Sunil,S., Hossain,M.J., Ramasamy,G. and Malhotra,P. (2008)
Transient silencing of Plasmodium falciparum Tudor Staphylococcal
Nuclease suggests an essential role for the protein. Biochem.
Biophys. Res. Commun., 372, 373–378.
17. Mohmmed,A., Dasaradhi,P.V., Bhatnagar,R.K., Chauhan,V.S. and
Malhotra,P. (2003) In vivo gene silencing in Plasmodium berghei –a
mouse malaria model. Biochem. Biophys. Res. Commun., 309,
506–511.
18. Sijwali,P.S. and Rosenthal,P.J. (2004) Gene disruption conﬁrms a
critical role for the cysteine protease falcipain-2 in hemoglobin
hydrolysis by Plasmodium falciparum. Proc. Natl Acad. Sci. USA,
101, 4384–4389.
19. Blackman,M.J. (2003) RNAi in protozoan parasites: what hope
for the Apicomplexa? Protist, 154, 177–180.
20. Ullu,E., Tschudi,C. and Chakraborty,T. (2004) RNA interference
in protozoan parasites. Cell Microbiol., 6, 509–519.
21. Gardner,M.J., Hall,N., Fung,E., White,O., Berriman,M.,
Hyman,R.W., Carlton,J.M., Nelson,K.E., Bowman,S., Paulsen,I.T.
et al. (2002) Genome sequence of the human malaria parasite
Plasmodium falciparum. Nature, 419, 498–511.
22. Hall,M., Karras,M., Raine,J.D., Carlton,J.M., Kooij,T.W.,
Berriman,M., Florens,L., Janssen,C.S., Pain,A., Christophides,G.K.
et al. (2005) A comprehensive survey of the Plasmodium life cycle by
genomic, transcriptomic, and proteomic analyses. Science, 307,
82–86.
23. Aravind,L., Iyer,L.M., Wellems,T.E. and Miller,L.H. (2003)
Plasmodium biology: genomic gleanings. Cell, 115, 771–785.
24. Cerutti,H. and Casas-Mollano,J.A. (2006) On the origin and
functions of RNA-mediated silencing: from protists to man. Curr.
Genet., 50, 81–99.
25. Rathjen,T., Nicol,C., McConkey,G. and Dalmay,T. (2006) Analysis
of short RNAs in the malaria parasite and its red blood cell host.
Febs Lett., 580, 5185–5188.
26. Xue,X., Zhang,Q., Huang,Y., Feng,L. and Pan,W. (2008)
No miRNA were found in Plasmodium and the ones identi-
ﬁed in erythrocytes could not be correlated with infection.
Malar. J., 10, 47.
27. de Koning-Ward,T.F., Speranca,M.A., Waters,A.P. and Janse,C.J.
(1999) Analysis of stage speciﬁcity of promoters in Plasmodium
berghei using luciferase as a reporter. Mol. Biochem. Parasitol., 100,
141–146.
28. Reed,M.B., Caruana,S.R., Batchelor,A.H., Thompson,J.K.,
Crabb,B.S. and Cowman,A.F. (2000) Targeted disruption of an
erythrocyte binding antigen in Plasmodium falciparum is associated
with a switch toward a sialic acid-independent pathway of invasion.
Proc. Natl Acad. Sci. USA, 97, 7509–7514.
29. Crabb,B.S., Triglia,T., Waterkeyn,J.G. and Cowman,A.F. (1997)
Stable transgene expression in Plasmodium falciparum. Mol.
Biochem. Parasitol., 90, 131–144.
30. Janse,C., Franke-Fayard,B. and Waters,A.P. (2006) High-eﬃciency
transfection and drug selection of genetically transformed blood
stages of the rodent malaria parasite Plasmodium berghei. Nat.
Protoc., 1, 614–623.
31. Crabb,B.S., Cooke,B.M., Reeder,J.C., Waller,R.F., Caruana,S.R.,
Davern,K.M., Wickham,M.E., Brown,G.V., Coppel,R.L. and
Cowman,A.F. (1997) Targeted gene disruption shows that knobs
enable malaria-infected red cells to cytoadhere under physiological
shear stress. Cell, 89, 287–296.
32. Duraisingh,M.T., Triglia,T., Ralph,S.A., Rayner,J.C.,
Barnwell,J.W., McFadden,G.I. and Cowman,A.F. (2003)
Phenotypic variation of Plasmodium falciparum merozoite proteins
directs receptor targeting for invasion of human erythrocytes.
EMBO J., 22, 1047–1057.
33. Duraisingh,M.T., Maier,A.G., Triglia,T. and Cowman,A.F. (2003)
Erythrocyte-binding antigen 175 mediates invasion in Plasmodium
falciparum utilizing sialic acid-dependent and -independent
pathways. Proc. Natl Acad. Sci. USA, 100, 4796–4801.
34. Baum,J., Richard,D., Healer,J., Rug,M., Krnajski,Z.,
Gilberger,T.W., Green,J.L., Holder,A.A. and Cowman,A.F. (2006)
A conserved molecular motor drives cell invasion and gliding
motility across malaria life cycle stages and other apicomplexan
parasites. J. Biol. Chem., 281, 5197–5208.
35. Baum,J., Maier,A.G., Good,R.T., Simpson,K.M. and
Cowman,A.F. (2005) Invasion by P. falciparum merozoites suggests
a hierarchy of molecular interactions. PLoS Pathog., 1, e37.
36. Ngo ˆ ,H., Tschudi,C., Gull,K. and Ullu,E. (1998) Double-stranded
RNA induces mRNA degradation in Trypanosoma brucei. Proc.
Natl Acad. Sci. USA, 95, 14687–14692.
37. Crabb,B.S., Cooke,B.M., Reeder,J.C., Waller,R.F., Caruana,S.R.,
Davern,K.M., Wickham,M.E., Brown,G.V., Coppel,R.L. and
Cowman,A.F. (1997) Targeted gene disruption shows that knobs
enable malaria-infected cells to cytoadhere under physiological
shear stress. Cell, 89, 287–296.
38. Dessens,J.T., Beetsma,A.L., Dimopoulos,G., Wengelnik,K.,
Crisanti,A., Kafatos,F.C. and Sinden,R.E. (1999) CTRP is
essential for mosquito infection by malaria ookinetes. EMBO J., 18,
6221–6227.
39. Baum,J., Papenfuss,A.T., Baum,B., Speed,T.P. and Cowman,A.F.
(2006) Regulation of apicomplexan actin-based motility. Nat. Rev.
Microbiol., 4, 621–628.
40. Robinson,K.A. and Beverley,S.M. (2003) Improvements in trans-
fection eﬃciency and tests of RNA interference (RNAi) approaches
in the protozoan parasite Leishmania. Mol. Biochem. Parasitol., 128,
217–228.
41. DaRocha,W.D., Otsu,K., Teixeira,S.M. and Donelson,J.E. (2004)
Tests of cytoplasmic RNA interference (RNAi) and construction of
a tetracycline-inducible T7 promoter system in Trypanosoma cruzi.
Mol. Biochem. Parasitol., 133, 175–186.
42. Chen,D.Q., Kolli,B.K., Yadava,N., Lu,H.G., Gilman-Sachs,A.,
Peterson,D.A. and Chang,K.P. (2000) Episomal expression of
speciﬁc sense and antisense mRNAs in Leishmania amazonensis:
modulation of gp63 level in promastigotes and their infection of
macrophages in vitro. Infect. Immun., 68, 80–86.
Nucleic Acids Research, 2009,Vol.37, No. 11 379743. Drozdz,M., Quijada,L. and Clayton,C.E. (2002) RNA interference
in trypanosomes transfected with sense and antisense plasmids.
Mol. Biochem. Parasitol., 121, 149–152.
44. Somanna,A., Mundodi,V. and Gedamu,L. (2002) Functional ana-
lysis of cathepsin B-like cysteine proteases from Leishmania
donovani complex. Evidence for the activation of latent transform-
ing growth factor beta. J. Biol. Chem., 277, 25305–25312.
45. Liang,X.H., Liu,Q. and Michaeli,S. (2003) Small nucleolar RNA
interference induced by antisense or double-stranded RNA in
trypanosomatids. Proc. Natl Acad. Sci. USA, 100, 7521–7526.
46. Touz,M.C., Conrad,J.T. and Nash,T.E. (2005) A novel palmitoyl
acyl transferase controls surface protein palmitoylation and
cytotoxicity in Giardia lamblia. Mol. Micro., 58, 999–1011.
47. Mundodi,V., Kucknoor,A.S. and Alderete,J.F. (2007) Antisense
RNA decreases AP33 gene expression and cytoadherence by
T. vaginalis. BMC. Microbiol., 7, 64.
48. Militello,K.T., Refour,P., Comeaux,C.A. and Duraisingh,M.T.
(2008) Antisense RNA and RNAi in protozoan parasites: Working
hard or hardly working? Mol. Biochem. Parasitol., 157, 117–126.
49. Militello,K.T., Patel,V., Chessler,A.D., Fisher,J.K., Kasper,J.M.,
Gunasekera,A. and Wirth,D.F. (2005) RNA polymerase II
synthesizes antisense RNA in Plasmodium falciparum. RNA, 11,
365–370.
50. Gunasekera,A.M., Patankar,S., Schug,J., Eisen,G., Kissinger,J.,
Roos,D. and Wirth,D.F. (2004) Widespread distribution of
antisense transcripts in the Plasmodium falciparum genome.
Mol. Biochem. Parasitol., 136, 35–42.
51. Patankar,S., Munasinghe,A., Shoaibi,A., Cummings,L.M. and
Wirth,D.F. (2001) Serial analysis of gene expression in Plasmodium
falciparum reveals the global expression proﬁle of erythrocytic
stages and the presence of anti-sense transcripts in the malarial
parasite. Mol. Biol. Cell, 12, 3114–3125.
52. Al Riyahi,A., Al-Anouti,F., Al-Rayes,M. and Ananvoranich,S.
(2006) Single argonaute protein from Toxoplasma gondii is involved
in the double-stranded RNA induced gene silencing. Int. J.
Parasitol., 36, 1003–1014.
53. Mello,C.C. and Conte,D. Jr. (2004) Revealing the world of RNA
interference. Nature, 431, 338–342.
54. Wickstead,B., Ersfeld,K. and Gull,K. (2003) Repetitive elements in
genomes of parasitic protozoa. Microbiol. Mol. Biol. Rev., 67,
360–375.
55. Gardiner,D.L., Holt,D.C., Thomas,E.A., Kemp,D.J. and
Trenholme,K.R. (2000) Inhibition of Plasmodium falciparum clag9
gene function by antisense RNA. Mol. Biochem. Parasitol., 110,
33–41.
3798 Nucleic Acids Research, 2009, Vol. 37,No. 11